osso esplosione spremere puma protein punta di freccia Specialità Mistero
PDF] Importance of proapoptotic protein PUMA in cell radioresistance. | Semantic Scholar
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy
ART increases PUMA protein level. PANC-1 (A), BxPC-3 (B), and HCT116... | Download Scientific Diagram
Life | Free Full-Text | BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis
Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by Arsenite | Molecular and Cellular Biology
PUMA decreases the growth of prostate cancer PC-3 cells independent of p53
PUMA-mediated apoptosis. PUMA is induced by a wide range of death... | Download Scientific Diagram
Inhibiting aberrant p53-PUMA feedback loop activation attenuates ischaemia reperfusion-induced neuroapoptosis and neuroinflammation in rats by downregulating caspase 3 and the NF-κB cytokine pathway | Journal of Neuroinflammation | Full Text
PDF] Importance of proapoptotic protein PUMA in cell radioresistance. | Semantic Scholar
Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells | PLOS ONE
PUMA (human)
a) Linear representation of the PUMA protein with each tyrosine, the... | Download Scientific Diagram
Expression and inhibitory effects of p53‑upregulated modulator of apoptosis in gallbladder carcinoma
Multimodal Interaction with BCL-2 Family Proteins Underlies the Proapoptotic Activity of PUMA BH3 - ScienceDirect
Human BBC3 / PUMA Protein Over-Expression Cell Culture Supernatant | LSBio
Opposite Effect: Protein Widely Known to Fight Tumors Also Boosts Cancer Growth
PUMA mediates the apoptotic response to p53 in colorectal cancer cells | PNAS
p53 and PUMA: A Deadly Duo | Science
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy